Literature DB >> 9890693

Bone mineral density in children with juvenile chronic arthritis.

A Cetin1, R Celiker, F Dinçer, M Ariyürek.   

Abstract

The aim of this study was to evaluate bone mineral density changes in patients with juvenile chronic arthritis (JCA) and to determine the most likely causes of osteoporosis in these patients. Eighteen (11 male, 7 female) patients suffering from JCA and 14 healthy controls (10 male, four female) were included in this study. The mean age of the patients and control groups were 11.0 +/- 3.2 and 10.9 +/- 2.9 years respectively. Disease activity was determined by clinical and laboratory evaluation and 'Articular Disease Severity Score' (ADSS). Bone mineral density (BMD) of the femoral neck and lumbar spine was measured by dual photon absorptiometry. BMD of the patients at the lumbar spine was significantly lower than the control group (p < 0.05). This difference was more marked in patients treated with steroids. Femoral neck BMD was also lower in the patient group but this difference was not statistically significant. There was a negative correlation between ADSS and BMD at the spine. In conclusion, trabecular bone loss is characteristic for osteoporosis in JCA. Our results indicate that steroid treatment and disease severity are important factors in the development of osteoporosis in JCA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9890693     DOI: 10.1007/bf01451301

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases.

Authors:  A Reed; M Haugen; L M Pachman; C B Langman
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

2.  Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate.

Authors:  L Lepore; M Pennesi; E Barbi; R Pozzi
Journal:  Clin Exp Rheumatol       Date:  1991 Jan-Feb       Impact factor: 4.473

3.  Evaluation by dual-photon absorptiometry of bone mineral loss in rheumatic children on long-term treatment with corticosteroids.

Authors:  F Fantini; P Beltrametti; M Gallazzi; M Gattinara; V Gerloni; M Murelli; M Parrini
Journal:  Clin Exp Rheumatol       Date:  1991 Jan-Feb       Impact factor: 4.473

4.  Bone mineral metabolism in juvenile chronic arthritis: the influence of steroids.

Authors:  M Bardare; M L Bianchi; M Furia; G G Gandolini; E Cohen; A Montesano
Journal:  Clin Exp Rheumatol       Date:  1991 Jan-Feb       Impact factor: 4.473

5.  Exercise response in children with and without juvenile rheumatoid arthritis: a case-comparison study.

Authors:  M J Giannini; E J Protas
Journal:  Phys Ther       Date:  1992-05

6.  Estimation of bone mineral density in children with juvenile rheumatoid arthritis.

Authors:  R Hopp; J Degan; J C Gallagher; J T Cassidy
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

7.  Osteoporosis in rheumatoid arthritis: effect of disease activity.

Authors:  R Celiker; Y Gökçe-Kutsal; A Cindas; M Ariyürek; N Renda; Z Koray; O Basgöze
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

Review 8.  Bone mineral metabolism in children with juvenile rheumatoid arthritis.

Authors:  J T Cassidy; C B Langman; S H Allen; L S Hillman
Journal:  Pediatr Clin North Am       Date:  1995-10       Impact factor: 3.278

  8 in total
  7 in total

1.  Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders.

Authors:  A M Huber; I Gaboury; D A Cabral; B Lang; A Ni; D Stephure; S Taback; P Dent; J Ellsworth; C LeBlanc; C Saint-Cyr; R Scuccimarri; J Hay; B Lentle; M Matzinger; N Shenouda; D Moher; F Rauch; K Siminoski; L M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-04       Impact factor: 4.794

Review 2.  Osteoporosis.

Authors:  R Cimaz; M Biggioggero
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

3.  Musculoskeletal and functional muscle-bone analysis in children with rheumatic disease using peripheral quantitative computed tomography.

Authors:  S Bechtold; P Ripperger; R Dalla Pozza; H Schmidt; R Häfner; H P Schwarz
Journal:  Osteoporos Int       Date:  2004-10-12       Impact factor: 4.507

4.  Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis.

Authors:  Reyhan Celiker; Serpil Bal; Aysin Bakkaloğlu; Eda Ozaydin; Turgay Coskun; Alp Cetin; Fitnat Dinçer
Journal:  Rheumatol Int       Date:  2003-03-12       Impact factor: 2.631

Review 5.  Glucocorticoid-induced osteoporosis in rheumatic diseases.

Authors:  Rosa Maria Rodrigues Pereira; Jozélio Freire de Carvalho; Ernesto Canalis
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

6.  Bone mineral status in children with congenital adrenal hyperplasia.

Authors:  Amy Fleischman; Julie Ringelheim; Henry A Feldman; Catherine M Gordon
Journal:  J Pediatr Endocrinol Metab       Date:  2007-02       Impact factor: 1.634

7.  Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases.

Authors:  Yuzaburo Inoue; Naoki Shimojo; Shuichi Suzuki; Takayasu Arima; Minako Tomiita; Masanori Minagawa; Yoichi Kohno
Journal:  Clin Rheumatol       Date:  2008-03-11       Impact factor: 2.980

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.